###begin article-title 0
miR-375 Targets 3'-Phosphoinositide-Dependent Protein Kinase-1 and Regulates Glucose-Induced Biological Responses in Pancreatic beta-Cells
###end article-title 0
###begin p 1
###xml 46 77 46 77 <email xmlns:xlink="http://www.w3.org/1999/xlink">emmanuel.van-obberghen@unice.fr</email>
Corresponding author: Emmanuel Van Obberghen, emmanuel.van-obberghen@unice.fr
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
OBJECTIVE-MicroRNAs are short, noncoding RNAs that regulate gene expression. We hypothesized that the phosphatidylinositol 3-kinase (PI 3-kinase) cascade known to be important in beta-cell physiology could be regulated by microRNAs. Here, we focused on the pancreas-specific miR-375 as a potential regulator of its predicted target 3'-phosphoinositide-dependent protein kinase-1 (PDK1), and we analyzed its implication in the response of insulin-producing cells to elevation of glucose levels.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 383 386 <span type="species:ncbi:10116">rat</span>
###xml 486 490 <span type="species:ncbi:10116">rats</span>
RESEARCH DESIGN AND METHODS-We used insulinoma-1E cells to analyze the effects of miR-375 on PDK1 protein level and downstream signaling using Western blotting, glucose-induced insulin gene expression using quantitative RT-PCR, and DNA synthesis by measuring thymidine incorporation. Moreover, we analyzed the effect of glucose on miR-375 expression in both INS-1E cells and primary rat islets. Finally, miR-375 expression in isolated islets was analyzed in diabetic Goto-Kakizaki (GK) rats.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 366 369 <span type="species:ncbi:10116">rat</span>
###xml 459 462 <span type="species:ncbi:10116">rat</span>
RESULTS-We found that miR-375 directly targets PDK1 and reduces its protein level, resulting in decreased glucose-stimulatory action on insulin gene expression and DNA synthesis. Furthermore, glucose leads to a decrease in miR-375 precursor level and a concomitant increase in PDK1 protein. Importantly, regulation of miR-375 expression by glucose occurs in primary rat islets as well. Finally, miR-375 expression was found to be decreased in fed diabetic GK rat islets.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-Our findings provide evidence for a role of a pancreatic-specific microRNA, miR-375, in the regulation of PDK1, a key molecule in PI 3-kinase signaling in pancreatic beta-cells. The effects of glucose on miR-375 are compatible with the idea that miR-375 is involved in glucose regulation of insulin gene expression and beta-cell growth.
###end p 6
###begin p 7
Published ahead of print at  on 30 June 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 32 36 32 36 <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" vol="57" page="2567" id="N0x43d6990N0x4298420" xlink:href="18820213" ext-link-type="pubmed">2567</related-article>
See accompanying commentary, p. 2567.
###end p 9
###begin p 10
###xml 65 66 65 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 420 421 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 422 423 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 480 481 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 482 483 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1023 1024 1008 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 1025 1026 1010 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 1134 1135 1116 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1252 1253 1234 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1490 1492 1472 1474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 1493 1495 1475 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 1714 1716 1696 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 1717 1719 1699 1701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 1828 1830 1804 1806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 47 53 <span type="species:ncbi:9606">people</span>
Type 2 diabetes currently affects >170 million people worldwide (1). The disease is characterized by an inability of the functional beta-cell mass to meet chronically increased metabolic demands for insulin, as occurring under variable states of insulin resistance. The normal beta-cell population can adapt to a sustained stimulation by recruiting beta-cells into a higher translational and insulin synthetic activity (2,3) and possibly by an expansion of its total cell number (4,5). The molecular mechanisms involved in this chronic adaptation of the beta-cell population are not completely understood. Several reports have highlighted the importance of phosphatidylinositol 3-kinase (PI 3-kinase) signaling in beta-cell physiology. For example, glucose stimulates the insulin gene promoter activity via a cascade involving PI 3-kinase. Indeed, glucose triggers phosphorylation of PDX-1 via the PI 3-kinase pathway, which induces nuclear translocation of PDX-1, and the latter then increases insulin gene transcription (6,7). Furthermore, glucose promotes beta-cell survival through the PI 3-kinase/protein kinase B (PKB) cascade (8). Different actors of the PI 3-kinase cascade have been identified as critical control points in insulin signaling (9), among them 3'-phosphoinositide-dependent protein kinase-1 (PDK1). This kinase was initially recognized by its ability to phosphorylate in the presence of lipid products generated by PI 3-kinase, the activation loop of PKB on Thr-308 (10,11). The role of PDK1 in vivo has been addressed in different organisms by genetic deletion of PDK1 homologs. In short, knockout studies revealed a central role of PDK1 in regulation of cell growth and organ development (12,13). Importantly, PDK1 ablation in beta-cells induces diabetes consecutively to a reduction in beta-cell mass (14).
###end p 10
###begin p 11
###xml 340 362 340 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans</italic>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 994 1004 994 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans</italic>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 1028 1038 1028 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 1127 1129 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 1150 1152 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 1153 1155 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 1165 1167 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 1180 1182 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 1223 1225 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 1226 1228 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 340 362 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 454 458 <span type="species:ncbi:10116">rats</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 484 490 <span type="species:ncbi:9606">humans</span>
###xml 994 1004 <span type="species:ncbi:6239">C. elegans</span>
###xml 1028 1038 <span type="species:ncbi:7227">Drosophila</span>
The discovery of microRNAs has opened an entirely new line of thoughts regarding the regulation of signaling by growth factors and hormones and its perturbations in situations associated to disease processes. MicroRNAs are 21- to 25-nucleotide-long noncoding RNA molecules first identified as regulators of the level of several proteins in Caenorhabditis elegans (15). Currently, hundreds of microRNAs have been cloned in mammalian species, i.e., 285 in rats, 442 in mice, and 533 in humans. They are collectively annotated and indexed in the microRNA registry (). Remarkably, some microRNAs are evolutionarily conserved, heralding important biological functions (16,17). Another feature of several microRNAs is their time- and tissue-specific expression, which points to their role in development and organ function. Since their discovery in 1993 by Lee et al. (15), a growing list of pleiotropic effects of microRNAs has appeared. Indeed, microRNAs have been shown to regulate development in C. elegans (18) and metabolism in Drosophila (19). More recently, they have been implicated in mammals in adipocyte differentiation (20), lipid metabolism (21,22), heart (23) and brain (24) development, and beta-cell physiology (25-27).
###end p 11
###begin p 12
###xml 307 309 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 723 726 <span type="species:ncbi:10116">rat</span>
###xml 958 962 <span type="species:ncbi:10116">rats</span>
###xml 977 988 <span type="species:ncbi:10116">Wistar rats</span>
Here, we were interested in identifying microRNAs targeting molecules involved in insulin signaling in pancreatic beta-cells. Using computational analysis, we found that miR-375, previously described as decreasing glucose-induced insulin secretion and characterized by pancreas-specific expression pattern (25), targets PDK1, a key player in the PI 3-kinase cascade. By gain- and loss-of-function experiments, we found that miR-375 regulates PDK1 protein level, resulting in modulation of glucose-stimulatory action on insulin gene expression and DNA synthesis. We showed that miR-375 interacts directly with the 3' untranslated region (3'UTR) of PDK1 mRNA. Furthermore, exposure of either INS-1E cells or freshly isolated rat islets to glucose modulates endogenous miR-375 precursor levels, suggesting its involvement in regulation of glucose responsiveness of beta-cells. Finally, miR-375 expression is found to be decreased in diabetic Goto-Kakizaki (GK) rats compared with Wistar rats.
###end p 12
###begin title 13
RESEARCH DESIGN AND METHODS
###end title 13
###begin title 14
Cell culture and transfections.
###end title 14
###begin p 15
###xml 189 190 185 186 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 310 311 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 555 558 540 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 578 581 563 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 694 695 678 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
INS-1E beta-cells were maintained in RPMI 1640 containing 11 mmol/l glucose supplemented with 10% (vol/vol) heat-inactivated FCS, 100 units/ml penicillin, 100 mug/ml streptomycin, 2 mmol/l l-glutamine, 10 mmol/l HEPES, 1 mmol/l sodium pyruvate, and 50 mumol/l beta-mercaptoethanol in humidified 5% (vol/vol) CO2, 95% (vol/vol) air at 37degreesC and used between passages 50 and 75. LipofectAMINE 2000 transfection reagent (Invitrogen, Life Technologies) was used to transfect INS-1E cells. A total of 3 mug pmiR-375 or pNeg and the indicated amounts of 2'-O-methyl-miR-375 or 2'-O-methyl-GFP antisense oligonucleotides and 2 mul LipofectAMINE 2000 were used per well with each containing 5 x 105 cells (six-well plate).
###end p 15
###begin title 16
Islet preparation.
###end title 16
###begin p 17
###xml 99 110 <span type="species:ncbi:10116">Wistar rats</span>
Islets were isolated by collagenase digestion, elutriation, and manual handpicking from adult male Wistar rats (150-250 g; Janvier, Le Genest Saint Isle France). Animals were bred according to Belgian regulations of animal welfare and used in experiments that were approved by the local ethical committee. Islets were cultured in Ham's F10 nutrient mixture (Gibco, Invitrogen, Carlsbad, CA) supplemented with 0.5% (wt/vol) BSA (Cohn Analog; Sigma), 2 mmol/l glutamine, 100 units/ml penicillin, 0.1 mg/ml streptomycin, 2% (vol/vol) FCS (Hyclone), and the indicated glucose concentration.
###end p 17
###begin title 18
Generation of DNA constructs.
###end title 18
###begin p 19
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 1075 1078 1075 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 1129 1132 1129 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 114 120 <span type="species:ncbi:10090">murine</span>
###xml 531 534 <span type="species:ncbi:10116">rat</span>
Expression vector driving expression of miR-375 was prepared by introducing oligonucleotides corresponding to the murine precursor sequence of mir-375 into pcDNA6.2 (pmiR-375) (Invitrogen). The oligonucleotide sequences were as follows: sense, 5'-TGCTGCCCCGCGACGAGCCCC-TCGCACAAACCGGACCTGAGCGTTTTGTTCGTTCGGCTCGCGTGAGGC-3'; and antisense, 5'-CCTGGCCTCACGCGAGCCGAACGAACAAAACGCTCAGGTCCGGTTTGTG CGAGGGGCTCGTCGCGGGGC-3'. As negative control, we used pNeg driving the expression of an unrelated known microRNA precursor (Invitrogen). The rat PDK1 3'UTR target site was cloned using the following oligonucleotides: sense, 5'-ACCCAACCACACAAAGAACAAAA-3'; and antisense, 5'-TTTTGTTCTTTGTGTGGTTGGGT-3' in the 3'UTR of the Renilla luciferase reporter vector, pmiR-Report luciferase (Ambion), as described previously (28). As a negative control response element, we used a mutated sequence by inserting the following oligonucleotides: sense, 5'-ACCCAACCACACCCCTCCTGGGG-3'; and antisense, 5'-CCCCAGGAGGGGTGTGGTT-GGGT-3'. Loss of function experiments were carried out using the following: 2'-O-methyl-375, UGCAUCACGCGAGCCGAACGAACAAAUAAGL, and 2'-O-methyl-eGFP, AAGGCAAGCUGACCCUGAAGUL.
###end p 19
###begin title 20
Luciferase assays.
###end title 20
###begin p 21
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
INS-1E cells were cultured in six-well plates and transfected with different reporter vectors (p-Luc-Empty, p-Luc 3'UTR PDK1 or p-Luc-3'UTR MUT PDK1) and cotransfected with pNeg or pmiR-375. Cells were assayed 48 h after transfection with the dual-luciferase reporter assay system (Promega, Madison, WI). Luciferase activity was normalized by beta-galactosidase activity.
###end p 21
###begin title 22
RNA RT-PCR and real-time PCR.
###end title 22
###begin p 23
###xml 326 328 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 398 400 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 36 39 <span type="species:ncbi:10116">rat</span>
RNA from transfected beta-cells and rat islets was isolated using TRIzol reagent (Invitrogen), and its quality was verified by Agilent Bioanalyzer (minimal cutoff RNA integrity number >/=8). From each transfected well, 1 mug total RNA was reverse-transcribed. For microRNAs precursor detection, RT was performed as described (29). MicroRNA precursor primer sequences are described by Jiang et al. (30). The following forward and reverse primers were used for amplification: PDK1, 5'-CCCACGTGATGGACTCAAAGA-3' (reverse) and 5'-AAGGGTACGGGCCTCTCAAA-3' (forward); Insulin-1, 5'-GTGCACCAACAGGGCCAT-3' (reverse) and 5'-CAGAGACCATCAGCAAGCAGG-3' (forward); U6, 5'-AACGCTTCACGAATTTGCGT-3' (reverse) and 5'-CTCGCTTCGGCAGCACA-3' (forward); and 36B4, 5'-ATGATCAGCCCGAAGGAGAAGG-3' (reverse) and 5'-CCACGAAAATCTCCAGAGGCAC-3' (forward).
###end p 23
###begin title 24
Analysis of total cell extracts and Western blotting.
###end title 24
###begin p 25
Two days after transfection, INS-1E cells were washed with ice-cold PBS and processed for protein isolation. For Western blotting, total proteins were separated by electrophoresis and transferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore, Bedford, MA) followed by blotting. Immunodetection was performed using affinity-purified polyclonal antibodies to PDK1 and phospho-glycogen synthase kinase (GSK)3 (Cell Signaling, Beverly, MA) and to phospho-Thr-308 PKB, total PKB, or total GSK3 (Santa Cruz Biotechnology, Santa Cruz, CA). To assess the total protein amount, membranes were stripped and reprobed with antibody to beta-tubulin (Sigma-Aldrich, St. Quentin-Fallavier, France).
###end p 25
###begin title 26
Cell viability assay.
###end title 26
###begin p 27
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
Cells (2 x 105 per well) seeded in 12-well plastic plates were transfected with pmiR-375 or pNeg and incubated at 37degreesC. After 48 h, cell viability was assessed by the ability of metabolically active cells to reduce tetrazolium salt to orange-colored formazan compounds. The absorbance of the samples was measured with a spectrophotometer reader (wavelength 450 nm). Data shown correspond to mean values from three independent experiments measured in sextuplicate.
###end p 27
###begin title 28
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
Measurement of DNA synthesis using [methyl-3H]thymidine incorporation.
###end title 28
###begin p 29
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 352 353 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 615 621 613 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methyl</italic>
###xml 622 623 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
Cells were plated in six-well plates at a density of 5 x 105 cells per well. After reaching 60% confluence, they were transfected with pmiR-375 or pNeg. Twenty-four hours later, cells were starved in RPMI containing 0.5% FCS (vol/vol) for 24 h and then replaced in RPMI 10% (vol/vol) FCS. After 24 h, DNA synthesis was assayed by adding 1 muCi [methyl-3H]thymidine/well and by incubating the cells for another 2 h. Then cells were washed twice with PBS, fixed with 10% (vol/vol) trichloroacetic acid for 30 min, and solubilized by adding 300 mul 0.2 N NaOH to each well. Radioactivity, reflecting incorporation of [methyl-3H]thymidine into DNA, was measured by adding scintillation liquid and counting.
###end p 29
###begin title 30
RESULTS
###end title 30
###begin title 31
miR-375 regulates PDK1 protein level.
###end title 31
###begin p 32
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 234 241 234 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 677 678 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 671 678 659 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 827 828 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 833 834 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 821 834 797 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic> and <italic>D</italic></xref>
###xml 876 877 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 870 877 846 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>E</italic></xref>
###xml 1192 1193 1168 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1319 1320 1295 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1426 1427 1390 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1450 1451 1414 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1444 1451 1408 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>F</italic></xref>
###xml 1487 1488 1451 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1503 1504 1467 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10116">rats</span>
###xml 403 409 <span type="species:ncbi:9606">humans</span>
To identify potential targets of miR-375, we used computational algorithms designed to predict mRNA targets of microRNAs. One of the predicted targets for miR-375 is PDK1. The predicted miR-375 binding site in the 3'UTR of PDK1 mRNA (Fig. 1A) appears to be phylogenetically maintained. This would suggest that the function of miR-375 as potential regulator of PDK1 has been conserved in mice, rats, and humans. To investigate whether miR-375 affects PDK1, plasmids driving the expression of miR-375 precursor (pmiR-375) or control (pNeg) were transfected in INS-1E cells. pmiR-375 increased miR-375 precursor levels by approximately500-fold, as assayed by real-time PCR (Fig. 1B). Functional analysis shows that miR-375 precursor overexpression in INS-1E cells results in a reduction of approximately40% of PDK1 protein (Fig. 1C and D) without affecting its mRNA level (Fig. 1E), indicating that miR-375 acts as a translational repressor. To evaluate whether the predicted miR-375 target site in the 3'UTR of PDK1 mRNA was directly involved in miR-375-induced reduction in PDK1 protein, we cloned the putative 3'UTR target site downstream of a luciferase reporter gene and cotransfected this p-Luc-3'UTR PDK1 construct into INS-1E cells with pmiR-375 or pNeg. Luciferase activity of cells transfected with pmiR-375 and p-Luc-3'UTR PDK1 was decreased by approximately25% compared with cells cotransfected with control pNeg and p-Luc-3'UTR PDK1 (Fig. 1F). With negative control constructs p-Luc-Empty and p-Luc-3'UTR MUT PDK1, no reduced luciferase activity was observed when cells were cotransfected with pmiR-375 compared with pNeg. Taken together, our data argue for a direct interaction between miR-375 and PDK1 mRNA.
###end p 32
###begin title 33
miR-375 decreases insulin signaling downstream of PDK1.
###end title 33
###begin p 34
###xml 816 817 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 822 823 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 810 823 797 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic> and <italic>B</italic></xref>
###xml 971 972 955 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 977 978 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 965 978 949 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic> and <italic>D</italic></xref>
The PI 3-kinase/PDK1/PKB signaling pathway is used by insulin in pancreatic beta-cells to elicit several actions of the hormone. It is generally believed that after insulin stimulation of cells, PDK1 is recruited to the plasma membrane and phosphorylates PKB on Thr-308, which becomes activated and phosphorylates a series of substrates, including GSK3alpha/beta. Downregulation of PDK1 in beta-cells is expected to cause a decrease in insulin-induced signaling dependent on this particular enzyme. To study the effect of miR-375 on insulin signaling, we examined the phosphorylation state of molecules functioning downstream of PDK1. Immunoblot analysis showed that in response to insulin, PKB phosphorylation on Thr-308 is less abundant in cells overexpressing miR-375 precursor compared with control cells (Fig. 2A and B). Consistent with this latter observation, ectopic expression of miR-375 precursor also reduces insulin-induced phosphorylation of GSK3beta (Fig. 2C and D).
###end p 34
###begin title 35
miR-375 decreases glucose-induced insulin gene expression and DNA synthesis.
###end title 35
###begin p 36
###xml 453 454 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 447 454 447 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 601 608 601 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methyl-</italic>
###xml 608 609 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 660 661 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 654 661 654 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
Because PI 3-kinase signaling has been implicated in glucose-induced upregulation of insulin gene expression and because we found that miR-375 decreases PDK1 protein, we examined the impact of miR-375 on insulin gene expression in response to glucose in INS-1E cells. We found that, as expected, high glucose concentration (20 mmol/l) induced insulin gene expression in control cells, but this effect was lost in cells overexpressing pre-miR-375 (Fig. 3A). To test whether PDK1 is involved in the glucose-induced increase in cell proliferative activity, we analyzed the impact of miR-375 on cellular [methyl-3H]thymidine incorporation. As illustrated in Fig. 3B, the stimulatory effect of glucose on DNA synthesis was reduced by approximately50% when miR-375 precursor was overexpressed.
###end p 36
###begin title 37
miR-375 attenuates cell viability and proliferation.
###end title 37
###begin p 38
###xml 395 396 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 389 396 377 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 444 445 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 438 445 414 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 549 556 525 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methyl-</italic>
###xml 556 557 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 602 603 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 596 603 572 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>C</italic></xref>
Because the PI 3-kinase/PKB cascade has been involved in cell survival and proliferation, we investigated the consequences of miR-375 expression on cell viability and proliferation. Thus, INS-1E cells were transfected with pmiR-375 or pNeg, and 48 h after transfection, cell number and viability were measured. We found that miR-375 overexpression reduced cell number by approximately25% (Fig. 4A) and cell viability by approximately20% (Fig. 4B). To further determine the effects of miR-375 on cell proliferation, DNA synthesis was measured using [methyl-3H]thymidine incorporation. As shown in Fig. 4C, transfection with miR-375 precursor inhibited INS-1E cell proliferative activity by 20% compared with control cells.
###end p 38
###begin title 39
###xml 2 5 2 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
2'-O-methyl-miR-375 increases PDK1 protein level and glucose-stimulatory action on insulin mRNA and DNA synthesis.
###end title 39
###begin p 40
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 444 447 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 469 470 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 475 476 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 463 476 451 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic> and <italic>B</italic></xref>
###xml 508 511 496 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 614 615 602 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 608 615 596 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 646 647 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 640 647 628 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>D</italic></xref>
###xml 652 655 640 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 715 716 703 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 758 761 746 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
Because miR-375 targets PDK1 and impairs glucose-stimulated insulin gene expression and cell proliferation, we investigated whether antisense oligonucleotides of miR-375 induce effects opposite to those seen after miR-375 overexpression. Using 2'-O-methyl-miR-375 antisense oligonucleotides, we found that blocking miR-375 augments PDK1 protein. This increase reaches approximately40% when cells are transfected with either 250 or 500 nmol/l 2'-O-methyl-miR-375 (Fig. 5A and B). Importantly, we found that 2'-O-methyl-miR-375-induced miR-375 depletion increases both basal and glucose-enhanced insulin mRNA (Fig. 5C). Finally, as shown in (Fig. 5D), 2'-O-methyl-miR-375 increases the glucose stimulatory action on [3H]thymidine incorporation compared with 2'-O-methyl-GFP.
###end p 40
###begin title 41
Glucose specifically decreases miR-375 expression.
###end title 41
###begin p 42
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 504 505 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 498 505 486 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 837 838 825 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 831 838 819 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 1071 1072 1059 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1065 1072 1053 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 1218 1219 1206 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1212 1219 1200 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>D</italic></xref>
To investigate whether glucose-induced responses in INS-1E cells could be mediated by microRNAs, we analyzed the expression of a series of microRNAs in cells maintained for 4 days with different glucose concentrations. Using quantitative RT-PCR as described previously (29), we found that miR-375 precursor is negatively regulated by glucose. Indeed, 11 and 22 mmol/l glucose induce a decrease of approximately60 and 70%, respectively, in miR-375 precursor levels compared with 5.5 mmol/l glucose (Fig. 6A). To look at whether this glucose effect was limited to miR-375, we measured the level of three other microRNAs expressed in INS-1E cells. In contrast to miR-375, both miR-296 and miR-9 are positively regulated by prolonged glucose treatment. Indeed, glucose leads to a concentration-dependent increase in miR-296 precursor (Fig. 6B), whereas miR-9 precursor is robustly increased after cell exposure to 11 mmol/l glucose. At higher glucose concentration, miR-9 expression tends to decline but remains higher compared with low glucose (5.5 mmol/l) condition (Fig. 6C). Finally, miR-122, which presents a specific liver expression, is detected in INS-1E cells, but glucose does not modulate its expression (Fig. 6D).
###end p 42
###begin title 43
The levels of miR-375 and PDK1 are inversely correlated in glucose-stimulated INS-1E cells.
###end title 43
###begin p 44
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 226 239 226 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>A</italic> and <italic>B</italic></xref>
###xml 389 390 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 383 390 383 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>C</italic></xref>
###xml 566 567 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 560 567 560 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>D</italic></xref>
###xml 714 715 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 708 715 708 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>E</italic></xref>
###xml 900 901 900 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 894 901 894 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>F</italic></xref>
To further document the role of miR-375, we analyzed the expression of premiR-375 in INS-1E cells treated for 1 or 24 h with 2 or 20 mmol/l glucose. We found that glucose induces a robust decrease in miR-375 after 1 and 24 h (Fig. 7A and B). Furthermore, immunoblot analyses show that PDK1 protein level is slightly, but not significantly, increased within 1 h of glucose treatment (Fig. 7C). Remarkably, in INS-1E cells exposed for 24 h to 20 mmol/l glucose, PDK1 protein is increased (fourfold), and its level thus inversely correlates with that of miR-375 (Fig. 7D). Finally, decreased miR-375 without change in PDK1 level seen after 1 h of glucose treatment occurs with enhanced insulin gene expression (Fig. 7E). Decreased miR-375 and increased PDK1 levels are associated with enhanced DNA synthesis as reflected by increased thymidine incorporation seen within 24 h of glucose treatment (Fig. 7F).
###end p 44
###begin title 45
###xml 57 60 <span type="species:ncbi:10116">rat</span>
Glucose regulates miR-375 expression in freshly isolated rat pancreatic islets.
###end title 45
###begin p 46
###xml 461 462 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 455 462 455 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>A</italic></xref>
###xml 628 629 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 622 629 622 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>B</italic></xref>
###xml 123 126 <span type="species:ncbi:10116">rat</span>
To characterize the glucose-mediated miR-375 regulation, we analyzed the expression level of miR-375 precursor in isolated rat islets that had been exposed to 5, 10, or 20 mmol/l glucose for 2- or 72-h periods, which represent conditions in which the acute and chronic influences, respectively, of glucose can be studied. After 2 h at stimulatory glucose concentrations (10 or 20 mmol/l), miR-375 expression is lower than in the basal 5 mmol/l condition (Fig. 8A). After 72 h, a lower expression level was measured at 5 mmol/l than at 10 and 20 mmol/l, whereas the level at 20 mmol/l tended to be lower than at 10 mmol/l (Fig. 8B).
###end p 46
###begin title 47
###xml 71 75 <span type="species:ncbi:10116">rats</span>
Reduced miR-375 expression in freshly isolated islets from diabetic GK rats.
###end title 47
###begin p 48
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 207 214 207 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>C</italic></xref>
###xml 369 370 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 363 370 363 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>E</italic></xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 501 502 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 495 502 495 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>D</italic></xref>
###xml 107 111 <span type="species:ncbi:10116">rats</span>
###xml 167 171 <span type="species:ncbi:10116">rats</span>
###xml 194 205 <span type="species:ncbi:10116">Wistar rats</span>
###xml 236 240 <span type="species:ncbi:10116">rats</span>
###xml 489 493 <span type="species:ncbi:10116">rats</span>
To study miR-375 expression under in vivo conditions of hyperglycemia, we analyzed islets from diabetic GK rats. We found that miR-375 is downregulated in diabetic GK rats compared with control Wistar rats (Fig. 8C). Furthermore, in GK rats, this decrease in miR-375 expression is associated with a modest, albeit not significant, increase in insulin mRNA level (Fig. 8E). Finally, the expression of miR-124a2, which has been involved in insulin mRNA expression (27), is upregulated in GK rats (Fig. 8D).
###end p 48
###begin title 49
DISCUSSION
###end title 49
###begin p 50
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 441 445 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mtpn</italic>
###xml 455 457 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
During recent years, microRNAs have emerged as important regulators of cell fate and metabolism. Although several microRNAs have been implicated in a variety of disease processes (31), only a few have been linked to insulin signaling and diabetes (32). Using either a gain- or loss-of-function approach, we show here in a pancreatic beta-cell line that miR-375, previously described to reduce glucose-induced insulin secretion by inhibiting Mtpn protein (25), is able to downregulate PDK1 protein by interfering directly with its mRNA. By targeting PDK1, a key player in the PI 3-kinase signaling cascade, miR-375 decreases insulin-induced phosphorylation of PKB and GSK3, both acting downstream of PDK1.
###end p 50
###begin p 51
###xml 170 172 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 361 363 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 285 294 <span type="species:ncbi:7955">zebrafish</span>
It is interesting to mention that pancreatic beta-cell specific PDK1 knockout in mice results in a reduced number and size of beta-cells, and in decreased islet density (14). These data and ours are intriguing in the context of a report showing that miR-375 knockout by morpholinos in zebrafish embryos leads to defects in the development of pancreatic islets (33).
###end p 51
###begin p 52
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 1273 1275 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 931 936 <span type="species:ncbi:10090">mouse</span>
###xml 993 999 <span type="species:ncbi:9606">humans</span>
###xml 1001 1005 <span type="species:ncbi:10090">mice</span>
###xml 1011 1015 <span type="species:ncbi:10116">rats</span>
Previous studies have shown that inhibition of the PI 3-kinase cascade dampens glucose-induced insulin gene expression (6). To document the biological role of miR-375 as an inhibitor of PI 3-kinase signaling downstream of PDK1, we analyzed the effect of miR-375 overexpression or depletion on glucose-induced insulin gene expression. Our findings that miR-375 controls insulin gene expression stimulated by glucose are consistent with the notion that the PI 3-kinase cascade is important for glucose stimulatory action on insulin gene expression. A chief observation of our study is that microRNA expression seems to be glucose sensitive. Importantly, the increased insulin gene expression seen in INS-1E cells exposed to high glucose is associated with reduced expression of miR-375 precursor. Our in silico analysis (data not shown) reveals that miR-375 is located in an intergenic region between cryba2 and Ccdc108 genes on the mouse chromosome 1. Comparison of genomic sequences () across humans, mice, and rats shows that a 5-kb genomic region downstream of the miR-375 precursor contains highly conserved elements. Moreover, according to a recent publication, several regions located downstream and upstream of the miR-375 gene interact with NeuroD1/BETA2 and PDX-1 (34). Taken together, these facts suggest that the gene encoding for miR-375 may behave as a locus controlled by its own promoter.
###end p 52
###begin p 53
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
Although glucose decreased miR-375 expression within 1 h in INS-1E cells, a longer exposure time was needed to observe the downstream stimulatory effect on PDK1 protein expression. This suggests that miR-375 suppresses synthesis of PDK1 protein. Interestingly, prolonged glucose exposure of INS-1E cells (35) has been shown to increase insulin receptor substrate 2 gene expression, protein localization to the plasma membrane, and PKB phosphorylation. These observations together with ours indicate that in INS-1E cells, glucose induces a decrease in miR-375 followed by an increase in PDK1 protein and an activation of the PI 3-kinase cascade and, hence, beta-cell proliferation.
###end p 53
###begin p 54
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 1055 1057 1055 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 1812 1814 1812 1814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 143 146 <span type="species:ncbi:10116">rat</span>
###xml 1006 1015 <span type="species:ncbi:7955">zebrafish</span>
###xml 1305 1309 <span type="species:ncbi:10116">rats</span>
###xml 1364 1375 <span type="species:ncbi:10116">Wistar rats</span>
###xml 1611 1615 <span type="species:ncbi:10116">rats</span>
Glucose was also found to regulate miR-375 expression in primary islet tissue. A 2-h incubation was used to measure levels in freshly isolated rat islets at glucose concentrations known to have exerted dose-dependent stimulations of their metabolic, secretory, and protein biosynthetic activities. We found miR-375 expression to be lower at 10 and 20 mmol/l than at 5 mmol/l glucose, which is similar to the effect seen in INS-1E cells. The 72-h culture condition compares expression in islets that have maintained this functional responsiveness (10 and 20 mmol/l glucose during culture) with that in islets having lost this responsiveness and showing increased susceptibility to apoptosis (5 mmol/l glucose during culture) (36-38). Expression of miR-375 is lower in islets showing viability consequences of prolonged glucose deprivation; it is unknown whether this reduction participates in the apoptotic pathway and can be interpreted in light of a report showing that miR-375 knockout by morpholinos in zebrafish leads to defects in islet development (33). When comparing functionally competent islets cultured at control (10 mmol/l) versus elevated (20 mmol/l) glucose concentrations, miR-375 levels appeared lower after prolonged glucose hyperactivation (20 mmol/l). Islets isolated from diabetic GK rats exhibited a lower miR-375 expression than islets from Wistar rats, which can be considered as further evidence for the suppressing effect of supraphysiological glucose concentrations. Such reduced miR-375 level is expected to be associated with increased insulin mRNA, but this was not the case in GK rats, suggesting a possible failure of the PDK1/PKB cascade to increase insulin gene expression. On the other hand, expression of miR-124a2, previously described as inhibiting insulin gene expression (27), is upregulated in GK islets. Hence, we speculate that the antagonizing actions of miR-124a2 and miR-375 are counterbalanced, resulting in an unchanged insulin mRNA level in GK islets. An alternative explanation is that the lower expression in GK islets results from a prolonged intracellular deprivation of glucose signals, as in the case of the islets cultured in 5 mmol/l glucose for 72 h that progress to apoptosis.
###end p 54
###begin p 55
###xml 29 31 29 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 268 270 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 446 448 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r41">41</xref>
###xml 730 732 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r42">42</xref>
###xml 895 897 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r43">43</xref>
###xml 898 900 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 328 333 <span type="species:ncbi:9606">human</span>
###xml 715 720 <span type="species:ncbi:9606">human</span>
According to recent studies (39,40), total beta-cell mass is reduced in patients and animals with type 2 diabetes and contributes to the disease process. Notably, beta-cell-specific PDK1 knockout in mice leads to diabetes as a result of a reduction in beta-cell mass (14). Another in vitro study reported that decreased PDK1 in human glioblastoma cells obtained with antisense oligonucleotides or with RNA interference blocks cell proliferation (41). Here, we find that miR-375 downregulates PDK1 by directly targeting PDK1 mRNA and may therefore impact on cell proliferation given its key role in the PI 3-kinase/PKB cascade. In this context, several studies have revealed dysregulations in microRNA expression in human cancers (42), suggesting that microRNAs may act on cell proliferation. More directly related to our work, recent studies show that miR-375 is decreased in pancreatic cancer (43-45). Our results point to a similar antiproliferative action of miR-375, because we found that miR-375 attenuates cell viability and proliferation.
###end p 55
###begin p 56
###xml 807 809 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
A first key finding of our work is that miR-375 is regulated by glucose, which is the central molecule in islet metabolism and physiology. A second important observation is that miR-375 inhibits glucose-induced INS-1E cell proliferation. This result is particularly interesting in the context of diabetes. Although a distinct disease process is responsible for type 1 and type 2 diabetes, in both cases, beta-cell failure occurs. Developing new approaches to induce beta-cells to replicate is a supereminent goal in diabetes research. Our data presented here reveal the pancreatic islet-specific microRNA, miR-375, as an important regulator of glucose-stimulated insulin gene expression and proliferation of pancreatic beta-cells. Taking into account the fact that miR-375 also decreases insulin secretion (25), miR-375 emerges as a target that should be prioritized to enhance islet function and to combat beta-cell failure.
###end p 56
###begin p 57
A.E.O. has received a PhD fellowship from la Ligue Nationale Contre le Cancer (France). D.P. has received Inter-University Pole Attraction Program Grant IUAP P5/17 from the Belgian Science Policy. E.V.O. has received a grant from the European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo-Nordisk Program in type 1 diabetes. This work has been supported by the Research Foundation Flanders (grant FWO-G.0183.05), the Institut National de la Sante et de la Recherche Medicale, the Universite de Nice-Sophia-Antipolis, the Conseil Regional Provence-Alpes-Cote d'Azur, the Conseil General des Alpes-Maritimes, and the European Community FP6 EUGENE2 (grant LSHM-CT-2004-512013).
###end p 57
###begin p 58
###xml 63 67 <span type="species:ncbi:10116">rats</span>
###xml 105 108 <span type="species:ncbi:10116">rat</span>
We thank Professor Bernard Portha for providing us with the GK rats; Dr. Olivier Dumortier for help with rat islets isolation; and Nadine Gautier, Chantal Filloux, Rachel Paul, Joseph Murdaca, Cyndie Raemdock, and Elke De Vos for assistance. We are grateful to Drs. Mourad Naimi and Jean Giudicelli for discussions and advice.
###end p 58
###begin title 59
REFERENCES
###end title 59
###begin p 60
###xml 29 30 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 509 510 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 632 633 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 640 641 635 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 650 651 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 871 872 864 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 878 879 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1527 1528 1512 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1535 1536 1520 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 98 101 <span type="species:ncbi:10116">rat</span>
###xml 107 112 <span type="species:ncbi:9606">human</span>
PDK1 is a target of miR-375. A: Scheme of the interaction between miR-375 and the 3'UTR of mouse, rat, and human PDK1. B: Quantification of miR-375 precursor levels. INS-1E cells were transfected with pNeg or pmiR-375 for 48 h. miR-375 precursor was then quantified by quantitative RT-PCR. Values for miR-375 precursor were normalized to U6 RNA. C: Analysis of PDK1 protein. INS-1E cells were transfected as above, and protein extracts were analyzed by Western blot using antibody to PDK1 or to beta-tubulin. D: Relative quantification of PDK1 protein. Data represent three independent transfections done in triplicate, +/-SE, with n = 3. *P < 0.05. E: Relative quantification of PDK1 mRNA levels. RNA extracts were used for quantitative RT-PCR analysis of PDK1 mRNA normalized to 36B4 mRNA. Data represent three independent transfections done in triplicate, +/-SE, with n = 3. F: Study of the interaction between miR-375 and 3'UTR of PDK1 mRNA. INS-1E cells were cotransfected with one of the following pmiR-reporter luciferase vectors (Ambion): empty vector, vector containing the 3'UTR PDK-1 oligonucleotide predicted to interact with miR-375, or vector containing a mutated sequence. The cells were also transfected with either pmiR-375 or pNeg. Forty-eight hours after transfection, cells were assayed for luciferase and beta-galactosidase activity; beta-galactodidase was used as control to normalize for transfection efficiency. Data represent three independent transfections, each carried out in duplicate, +/-SE, with n = 3. *P < 0.05.
###end p 60
###begin p 61
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 465 466 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 603 604 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 749 750 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 757 758 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Effect of miR-375 on PKB and GSK3 phosphorylation. A: Analysis of Thr-308-phosphorylation of PKB. INS-1E cells were transfected with pNeg or pmiR-375. Forty-eight hours later, cells were starved in Krebs-Ringer bicarbonate HEPES medium for 2 h and either were or were not stimulated with 100 nmol/l insulin for 5 min. Protein extracts were analyzed by Western blot using antibody to phospho308Thr PKB and total PKB. B: Quantification of Thr-308-phosphorylated PKB. C: Analysis of GSK3beta phosphorylation. Protein extracts were analyzed by Western blot using antibody to phosphoGSK3beta and total GSK3. D: Quantification of phosphorylated GSK3beta. The data presented correspond to three independent experiments, each done in duplicate, +/-SE, with n = 3. *P < 0.05.
###end p 61
###begin p 62
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 506 507 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 514 515 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 526 527 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 537 538 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 563 564 561 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 856 857 854 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 961 962 957 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 969 970 965 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Effect of miR-375 on glucose-enhanced insulin gene expression and cell proliferation. A: Quantification of insulin mRNA. INS-1E cells were transfected as above. Forty-eight hours later, cells were starved in RPMI 1640 with 0.5% (vol/vol) FCS containing 2 mmol/l glucose for 16 h and treated with 2 or 20 mmol/l glucose for 1 h. Insulin mRNA expression was analyzed by quantitative RT-PCR and normalized to 36B4 transcript. Data represent five independent experiments carried out in triplicate, +/-SE, with n = 5. *P < 0.05, **P < 0.005. B: Measurement of [methyl-3H]thymidine incorporation. INS-1E cells were transfected as above. Twenty-four hours later, cells were starved in RPMI 1640 with 0.5% (vol/vol) FCS containing 2 mmol/l glucose for 16 h and treated with 2 or 20 mmol/l glucose for 24 h, and cell proliferation was assessed by measuring [methyl-3H]thymidine incorporation. Data represent three independent experiments done in triplicate, +/-SE, with n = 3. *P < 0.05.
###end p 62
###begin p 63
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 405 406 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 480 481 480 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 583 610 583 610 <sc xmlns:xlink="http://www.w3.org/1999/xlink">research design and methods</sc>
###xml 693 694 691 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 701 702 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 711 712 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 737 738 735 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 809 810 807 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 835 836 833 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 891 892 889 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1001 1002 997 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1009 1010 1005 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Effect of miR-375 on cell number, viability, and proliferation. A: Cell number counting. INS-1E cells were seeded in six-well plates (5 x 105/well) and transfected with pNeg or premiR-375. Cells were starved in RPMI 1640 containing 0.5% (vol/vol) FCS and 11 mmol/l glucose for 24 h and then replaced in RPMI 1640 10% (vol/vol) FCS and 11 mmol/l glucose for 24 h. Cells were counted using Coulter counter. B: Cell viability assay. INS-1E cells were seeded in 12-well plates (2 x 105/well) and transfected as above. Forty-eight hours later, cell viability was assessed as described in research design and methods. Data represent three independent transfections done in sextuplicate, +/-SE, with n = 3. *P < 0.05. C: Measurement of [methyl-3H]thymidine incorporation. Cells were seeded in six-well plates (5 x 105/well) and treated as in A. Cell proliferation was assessed by measuring [methyl-3H]thymidine incorporation. Data represent three independent experiments, each run in triplicate, +/-SE, with n = 3. *P < 0.05.
###end p 63
###begin p 64
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 208 211 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 329 330 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 424 425 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 433 434 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 443 444 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 528 531 523 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 547 550 542 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 961 962 954 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 969 970 962 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 981 982 974 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 991 992 984 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1017 1018 1010 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1275 1276 1268 1269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1393 1394 1384 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1401 1402 1392 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1414 1415 1405 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Effect of 2'-O-methyl-miR-375 antisense oligonucleotides on PDK1, glucose-enhanced insulin mRNA, and cell proliferation. A: Analysis of PDK1 protein. INS-1E cells were transfected with indicated amounts of 2'-O-methyl-miR-375. After 48 h, protein extracts were analyzed by Western blot using antibody to PDK1 or to beta-tubulin. B: Quantification of PDK1 protein. Data represent three independent transfections, +/-SE, with n = 3. **P < 0.01. C: Quantification of insulin mRNA level. INS-1E cells were transfected with either 2'-O-methyl-GFP or 2'-O-methyl-miR-375 at 500 nmol/l. Twenty-four hours later, cells were starved in RPMI 1640 with 0.5% (vol/vol) FCS containing 2 mmol/l glucose for 16 h and treated with 2 or 20 mmol/l glucose for 1 h. RNA extracts were reverse-transcribed and analyzed by RT-PCR for the expression of insulin gene normalized to the 36B4 transcript level. Data represent three independent experiments done in triplicate, +/-SE, with n = 3. *P < 0.05, **P < 0.01. D: Measurement of [methyl-3H]thymidine incorporation. INS-1E cells were transfected as described above. Twenty-four hours later, cells were starved in RPMI 1640 with 0.5% (vol/vol) FCS containing 2 mmol/l glucose for 16 h and treated with 2 or 20 mmol/l glucose for 24 h, and [methyl-3H]thymidine incorporation was measured. Data represent four independent experiments, done in triplicate, +/-SE, with n = 4. *P < 0.05, ***P < 0.001.
###end p 64
###begin p 65
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 369 370 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 393 394 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 581 582 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 589 590 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 601 602 599 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Expression of microRNAs in glucose-stimulated INS-1E cells. INS-1E cells were cultured in six-well plates (5 x 105/well) and starved in RPMI 1640 with 0.5% (vol/vol) FCS containing 2 mmol/l glucose for 24 h and thereafter treated with 5.5, 11, or 22 mmol/l glucose for 4 days. RNA extracts were reverse-transcribed and analyzed by RT-PCR for the expression of miR-375 (A), miR-296 (B), miR-9 (C), and miR-122 (D) precursors. Expression levels of microRNA precursors were normalized to U6 transcript. Data represent three independent experiments each done in duplicate, +/-SE, with n = 3. *P < 0.05, **P < 0.005. Results were expressed relative to the low glucose condition (5.5 mmol/l Glc).
###end p 65
###begin p 66
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 284 285 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 296 297 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 485 486 485 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 738 739 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 750 751 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 807 808 804 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 912 913 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 920 921 915 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 932 933 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Effect of glucose on endogenous miR-375 and PDK1 expression in INS-1E cells. INS-1E cells were cultured in six-well plates (5 x 105/well) and starved in RPMI 1640 with 0.5% (vol/vol) FCS containing 2 mmol/l glucose for 24 h and thereafter treated with 2 or 20 mmol/l glucose for 1 h (A) or 24 h (B). RNA extracts were analyzed for miR-375 precursor. Expression of miR-375 precursor was normalized to the U6 transcript level. Protein extracts from cells stimulated for 1 h (C) or 24 h (D) with 2 or 20 mmol/l glucose were analyzed by Western blot using antibody to PDK1 or to beta-tubulin. INS-1E cells were starved in RPMI 1640 with 0.5% (vol/vol) FCS containing 2 mmol/l glucose for 16 h and treated with 2 or 20 mmol/l glucose for 1 h (E) or 24 h (F). Cell proliferation was assessed by measuring [methyl-3H]thymidine incorporation. Data represent three independent experiments done in triplicate, +/-SE, with n = 3. *P < 0.05, **P < 0.005.
###end p 66
###begin p 67
###xml 112 139 112 139 <sc xmlns:xlink="http://www.w3.org/1999/xlink">research design and methods</sc>
###xml 417 418 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 429 430 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 631 632 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 650 651 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 662 663 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 710 711 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 730 731 728 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 843 844 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 862 863 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 884 885 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 914 915 910 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 935 936 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 951 952 947 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 59 62 <span type="species:ncbi:10116">rat</span>
###xml 71 74 <span type="species:ncbi:10116">Rat</span>
###xml 724 728 <span type="species:ncbi:10116">rats</span>
Study of endogenous miR-375 expression in freshly isolated rat islets. Rat islets were isolated as described in research design and methods. Islets were maintained overnight in Ham's F10 containing 1.8 g/l glucose supplemented with 300 mg/l glutamine, 100 mg/l streptomycin, 75 mg/l penicillin, 0.5% (wt/vol) BSA, and 2% (vol/vol) FCS. Thereafter, islets were treated with either 5, 10, or 20 mmol/l glucose for 2 h (A) or 72 h (B). RNA extracts were reverse-transcribed and analyzed by quantitative RT-PCR for miR-375 precursor. Expression of miR-375 precursor was normalized to the U6 transcript level. Results are means +/- SE (n = 3/condition). *P < 0.05, **P < 0.005. Freshly isolated islets from Wistar (n = 5) and GK rats (n = 6) were prepared as previously described. RNA extracts were analyzed by quantitative RT-PCR for pre-miR-375 (C), pre-miR-124a2 (D), and insulin mRNA (E). Results are means +/- SE (n = 5 for Wistar and n = 6 for GK), *P < 0.05.
###end p 67

